CLDN6 and neoplasm: McDermott et al. utilized flow cytometry in the selection of monoclonal antibodies (mAbs) that bound to the tumor-expressed claudin-6 (CLDN6) with minimal binding to related family members CLDN3 and CLDN9 that are widely expressed in healthy tissues [19,20,21].